We are pleased to introduce the Latin American Trials and Research Network (LATIN) which is coordinated by the Chang Lab at George Washington University (GWU) and now part of the ISARIC Consortium.

The Latin American Trials and Research Network (LATIN) is a consortium of acute febrile illness monitoring sites and clinical trial sites in Latin America, coordinated by George Washington University (GWU). Its main objective is to establish a collaborative platform for the execution of high-quality and efficient clinical trials in Latin America, focusing on therapies for arboviral infections and other emerging viral threats to fast-track therapies.
Key Points of the Project:
- Execution of clinical trials with standardized and adaptable protocols.
- Participation in the LATIN Network will facilitate opportunities for global clinical trials in infectious diseases.
- Regulatory coordination to minimize delays in treatment development.
- Monitoring of acute febrile illnesses for rapid responses to new viral threats.
- The Coordinating Center (GWU) oversees implementation and regulatory compliance across institutions.
- Committees and working groups dedicated to optimizing trials, regulations, and publication strategies.
This initiative aims to strengthen research capacity in the region, improve access to innovative therapies, and accelerate responses to future pandemics.

LATIN Network Partners
We are proud to collaborate with esteemed research institutions and healthcare centers that are instrumental in advancing infectious disease research: